ArticleBMC veterinary research2018

Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer.

Xóchitl Zambrano-Estrada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.